This CME Symposium takes place at The Preventive Cardiovascular Nurses Association 20th Annual Symposium on Thursday April 10, 2014 from 8:45 AM - 9:45 AM at the Atlanta Marriott Marquis, Imperial Ballroom, Marquis Level in Atlanta, Georgia.
PRLog - Feb. 28, 2014 - ATLANTA -- Click to Register Online
Improving Outcomes in Acute Coronary Syndromes: Exploring Oral Antiplatelet Therapies and Transitions of Care
Faculty
Jeffrey Berger, MD
Assistant Professor of Medicine
New York University School of Medicine
New York, New York
Kim Newlin, RN, CNS, NP-C, FPCNA
Sutter Roseville Medical Center
Roseville, California
Click To Register Online
Acute coronary syndrome (ACS) patients require dual oral antiplatelet therapy (DAPT)--aspirin plus a P2Y12 inhibitor--for in-hospital and post-hospital discharge management. The landscape of oral antiplatelet therapy has changed, with three P2Y12 receptor inhibitors available—clopidogrel, prasugrel, and ticagrelor. In addition to oral antiplatelet therapy after an ACS, other interventions (lifestyle and pharmacologic) are recommended to reduce the risk of another ischemic event. This program will address pharmacologic profiles of antiplatelet drugs, efficacy and safety data with antiplatelet therapies from ACS clinical trials, and appropriate use of DAPT in the short-term and long-term management of ACS patients. A case presentation will enable attendees to interact with faculty members regarding prudent secondary prevention in a patient who has experienced an ACS.
This educational activity is provided by the Preventative Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program is accredited for 1 contact hour of continuing education. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.
PCNA and Voxmedia International gratefully acknowledge the educational grant provided by AstraZeneca Pharmaceuticals LP.
Pre-registration is for planning purposes only.
For additional CME activities and online cme courses visit CMEPlanet
Read Full Story - CME Symposium - Improving Outcomes in Acute Coronary Syndromes | More news from this source
Press release distribution by PRLog
CME Symposium - Improving Outcomes in Acute Coronary Syndromes
February 28, 2014 at 12:02 PM EST
